• Columbia University (B.A., 2004)
  • Emory University School of Law (J.D., 2007, with high honorsOrder of the Coif)


  • District of Columbia and New York


Gary Feldon practices in the Firm’s Complex Litigation and Toxic Torts & Products Liability groups. He is a member of one of the Firm’s trial teams defending against serial litigation involving cancer allegations related to claimed exposure to ethylene oxide.

Prior to joining the Firm, Mr. Feldon served as a Trial Attorney at the Federal Programs Branch of the U.S. Department of Justice, where he defended the United States in federal district courts against complex and high-impact constitutional, administrative, and statutory challenges. In that capacity, he served as lead counsel in more than thirty cases and advised on appellate matters in the U.S. Supreme Court and U.S. Courts of Appeal. Matters on which he worked included representing federal agencies' interests in two multidistrict litigations — the National Prescription Opiate Litigation and 3M Combat Arms Earplug Products Liability Litigation — and defending the Department of Agriculture against class action challenges to a debt relief program under the American Rescue Plan Act.

Mr. Feldon also worked as a Trial Attorney at the Equity Section of the Office of the Attorney General for the District of Columbia, where he served as lead counsel for the District of Columbia in class actions, complex constitutional and statutory litigation, and politically sensitive cases. Among other matters, he won summary judgment on two putative class actions alleging employment discrimination by current and former District of Columbia employees.

Prior to his work in government, Mr. Feldon was in private practice where he represented clients in the pharmaceutical and transportation industries in arbitration, at trial, and on appeal.

Following law school, Mr. Feldon clerked for the Honorable Edward E. Carnes of the Eleventh Circuit. During law school, he was Executive Articles Editor for the Emory International Law Review.